First Pharmaceutical Drug To Improve Survival Amongst Patients With Advanced Hepatocarcinoma »
Posted by: dirtyfratboy 2 months agoInternational research involving the University Hospital of the University of Navarra, together with other hospitals in Spain, has shown that Sorafenib, an orally administered pharmaceutical medicine, results in patients with primary hepatocarcinomas (liver tumours) to live 40% more on average compared to those not taking the drug.
Read Full Story at sciencedaily.com
Submitted By:
dirtyfratboyHey all, I'm Henry. I'm a student right now and I'll be majoring in Business at the University of Illinois Urbana-Champaign. During ...
Related Articles:
Why not submit a story?
Also Propping This Article
Groups Watching This
No groups are watching this story. Why not share it with your group?




